Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Clinical cases employing novel agents in Hodgkin lymphoma

Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Centre, New York, USA
Clinical cases employing novel agents in Hodgkin lymphoma ( Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Centre, New York, USA )
29 Apr 2016

Chronic lymphocytic leukaemia: Transition to a new era

Prof Stephen Mulligan - Royal North Shore Hospital, Australia
Chronic lymphocytic leukaemia: Transition to a new era ( Prof Stephen Mulligan - Royal North Shore Hospital, Australia )
29 Apr 2016

The role of the microenvironment and novel therapies in CLL

Prof Jan Burger - MD Anderson Cancer Center, Texas, USA
The role of the microenvironment and novel therapies in CLL ( Prof Jan Burger - MD Anderson Cancer Center, Texas, USA )
29 Apr 2016

Targeted therapy shows continued promise in patients whose tumours had NTRK gene fusions

Dr David Hong - University of Texas MD Anderson Cancer Center, Houston, USA
Targeted therapy shows continued promise in patients whose tumours had NTRK gene fusions ( Dr David Hong - University of Texas MD Anderson Cancer Center, Houston, USA )
29 Apr 2016

Combination therapy before surgery improves outcomes for patients with HER2 positive breast cancer

Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania, Philadelphia, USA
Combination therapy before surgery improves outcomes for patients with HER2 positive breast cancer ( Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania, Philadelphia, USA )
28 Apr 2016

Identifying myeloid-driven biologies

Dr Brian Ruffell - Moffitt Cancer Center, Tampa, USA
Identifying myeloid-driven biologies ( Dr Brian Ruffell - Moffitt Cancer Center, Tampa, USA )
28 Apr 2016

Metastasis intiation mediated by thrombospondin 2

Dr Ilaria Malanchi - Crick Institute, London, UK
Metastasis intiation mediated by thrombospondin 2 ( Dr Ilaria Malanchi - Crick Institute, London, UK )
27 Apr 2016

AML17 Trial results: maximum dosage of daunorubicin in AML

Dr Mike Dennis - Christie Hospital NHS Foundation Trust, Manchester, UK
AML17 Trial results: maximum dosage of daunorubicin in AML ( Dr Mike Dennis - Christie Hospital NHS Foundation Trust, Manchester, UK )
27 Apr 2016

AML during pregancy

Dr Sahra Ali - Hull and East Yorkshire Hospitals NHS Trust, Hull, UK
AML during pregancy ( Dr Sahra Ali - Hull and East Yorkshire Hospitals NHS Trust, Hull, UK )
27 Apr 2016

BSH 2016: Expert discussion on idelalisib

Dr George Follows and Dr Andrew Zelenetz
BSH 2016: Expert discussion on idelalisib ( Dr George Follows and Dr Andrew Zelenetz )
27 Apr 2016

Next-generation sequencing in the lymphoid malignancies

Dr Aaron Logan - UCSF, San Fransisco, USA
Next-generation sequencing in the lymphoid malignancies ( Dr Aaron Logan - UCSF, San Fransisco, USA )
26 Apr 2016

Risk of breast cancer after chest radiotherapy may be affected by genetics

Dr Lindsay Morton - National Cancer Institute, Bethesda, USA
Risk of breast cancer after chest radiotherapy may be affected by genetics ( Dr Lindsay Morton - National Cancer Institute, Bethesda, USA )
26 Apr 2016